(AAME) Atlantic American - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0482091008
AAME EPS (Earnings per Share)
AAME Revenue
AAME: Property, Casualty, Life, Health, Surety
Atlantic American Corporation is a US-based insurance provider operating through two main segments: American Southern and Bankers Fidelity. The company offers a diverse range of insurance products, including property and casualty insurance, life insurance, and health insurance. Its property and casualty insurance products cater to state governments, municipalities, and other organizations, while its life and health insurance products are marketed to individuals and groups. The companys insurance offerings are distributed through independent agents and brokers.
From a business perspective, Atlantic American Corporation has a long history dating back to 1937, and it is headquartered in Atlanta, Georgia. As a subsidiary of Atlantic American / Delta Group, the company has a established presence in the US insurance market. Its product portfolio includes specialized insurance products such as surety bond coverage, Medicare supplement insurance, and short-term care products. The companys ability to offer a range of insurance products positions it to capitalize on opportunities in the US insurance market.
Analyzing the
Considering the
Combining the insights from both technical and fundamental data, we forecast that Atlantic American Corporations stock price may experience a short-term correction due to the companys unprofitable financial performance. However, the stocks positive trend and moderate volatility suggest that it may be poised for a rebound if the company can improve its financials. A potential trading strategy could involve monitoring the stocks price action around the $1.64 (SMA20) and $1.54 (SMA50) levels, as a break above or below these levels could indicate a change in the stocks trend. In the short term, we predict that the stock price will trade between $1.60 and $1.80. To mitigate potential risks, investors should closely monitor the companys future financial reports and adjust their strategies accordingly.
Additional Sources for AAME Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
AAME Stock Overview
Market Cap in USD | 35m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception | 1980-04-11 |
AAME Stock Ratings
Growth Rating | -15.9 |
Fundamental | 10.4 |
Dividend Rating | 13.6 |
Rel. Strength | -11.2 |
Analysts | - |
Fair Price Momentum | 1.92 USD |
Fair Price DCF | 9.40 USD |
AAME Dividends
Dividend Yield 12m | 1.16% |
Yield on Cost 5y | 1.13% |
Annual Growth 5y | 0.00% |
Payout Consistency | 31.6% |
Payout Ratio | 14.3% |
AAME Growth Ratios
Growth Correlation 3m | 70.4% |
Growth Correlation 12m | 5.7% |
Growth Correlation 5y | -61.9% |
CAGR 5y | 1.14% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -0.07 |
Alpha | 4.51 |
Beta | 0.172 |
Volatility | 47.72% |
Current Volume | 5.1k |
Average Volume 20d | 4.6k |
As of June 19, 2025, the stock is trading at USD 1.87 with a total of 5,135 shares traded.
Over the past week, the price has changed by +3.31%, over one month by +8.72%, over three months by +33.73% and over the past year by +9.76%.
Neither. Based on ValueRay´s Fundamental Analyses, Atlantic American is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.36 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AAME is around 1.92 USD . This means that AAME is currently overvalued and has a potential downside of 2.67%.
Atlantic American has no consensus analysts rating.
According to our own proprietary Forecast Model, AAME Atlantic American will be worth about 2.1 in June 2026. The stock is currently trading at 1.87. This means that the stock has a potential upside of +10.7%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 2.1 | 10.7% |